Simplify Asset Management »

Fulcrum Therapeutics shares owned by Simplify Asset Management

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Simplify Asset Management from 13F filings

Historical chart of Simplify Asset Management investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Simplify Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Simplify Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.8M 563k 6.75
2023-09-30 $2.5M 571k 4.44
2023-06-30 $2.3M 696k 3.30
2023-03-31 $1.8M 639k 2.85

More positions owned by Simplify Asset Management

Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Ishares Tr Core S&p500 Etf (IVV)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Simplify Exchange Traded Fun Stable Incm Etf (BUCK)
Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Pimco Etf Tr 15+ Yr Us Tips (LTPZ)
Tesla Motors Call Option (TSLA)
Applied Therapeutics (APLT)
Ishares Tr Core Us Aggbd Et (AGG)
Simplify Exchange Traded Fun Short Term Trea (TUA)
Ishares Tr Mbs Etf (MBB)
Tscan Therapeutics (TCRX)
Simplify Exchange Traded Fun High Yield Plus (CDX)

View all positions for Simplify Asset Management

Top funds holding Fulcrum Therapeutics

RA Capital Management
Cowen And Company
Vanguard Group
Trv Gp Iv
Citadel Advisors
Logos Global Management
Dimensional Fund Advisors
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Propel Bio Management
ADAR1 Capital Management
Simplify Asset Management
Marshall Wace
D. E. Shaw & Co
Two Sigma Advisers

View all funds holding Fulcrum Therapeutics